• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疱疹药物对不同水痘-带状疱疹病毒株的疗效比较

Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.

作者信息

Shigeta S, Yokota T, Iwabuchi T, Baba M, Konno K, Ogata M, De Clercq E

出版信息

J Infect Dis. 1983 Mar;147(3):576-84. doi: 10.1093/infdis/147.3.576.

DOI:10.1093/infdis/147.3.576
PMID:6300257
Abstract

Twenty antiherpes compounds were compared for their inhibitory activities against five laboratory strains and five clinical isolates of varicella-zoster virus (VZV) in human embryo fibroblast cultures. E-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), E-5-(2-iodovinyl)-2'-deoxyuridine (IVDU), and E-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) were the most effective. The average values of the 50% inhibitory dose (ID50) for VZV replication were 0.0013, 0.0015, and 0.0024 micrograms/ml, respectively. 1-beta-D-Arabinofuranosyladenine and 9-(2-hydroxyethoxymethyl)guanine were 1.2 and 3.4 times less effective than 5-iodo-2'-deoxyuridine (IDU). The selectivity indexes (ratio of ID50 for host-cell DNA synthesis to ID50 for VZV replication) of BVaraU, IVDU, and BVDU were between 41,000 and 67,000, whereas those of cytosine arabinoside, IDU, and 5-bromo-2'-deoxyuridine were less than 1.1. BVaraU, IVDU, and BVDU were the most potent and the most selective inhibitors of VZV activity. A deoxythymidine kinase deficient mutant of VZV was resistant to most of the compounds tested at concentrations up to 36,000 times greater than the average ID50 for strains that were not deficient.

摘要

在人胚成纤维细胞培养物中,比较了20种抗疱疹化合物对水痘 - 带状疱疹病毒(VZV)的5个实验室菌株和5个临床分离株的抑制活性。E - 5 -(2 - 溴乙烯基)-1 - β - D - 阿拉伯呋喃糖基尿嘧啶(BVaraU)、E - 5 -(2 - 碘乙烯基)-2'-脱氧尿苷(IVDU)和E - 5 -(2 - 溴乙烯基)-2'-脱氧尿苷(BVDU)最为有效。VZV复制的50%抑制剂量(ID50)的平均值分别为0.0013、0.0015和0.0024微克/毫升。1 - β - D - 阿拉伯呋喃糖基腺嘌呤和9 -(2 - 羟基乙氧基甲基)鸟嘌呤的效力分别比5 - 碘 - 2'-脱氧尿苷(IDU)低1.2倍和3.4倍。BVaraU、IVDU和BVDU的选择性指数(宿主细胞DNA合成的ID50与VZV复制的ID50之比)在41,000至67,000之间,而阿糖胞苷、IDU和5 - 溴 - 2'-脱氧尿苷的选择性指数小于1.1。BVaraU、IVDU和BVDU是VZV活性最有效和最具选择性的抑制剂。VZV的一种脱氧胸苷激酶缺陷型突变体对所测试的大多数化合物具有抗性,其浓度比非缺陷菌株的平均ID50高36,000倍。

相似文献

1
Comparative efficacy of antiherpes drugs against various strains of varicella-zoster virus.抗疱疹药物对不同水痘-带状疱疹病毒株的疗效比较
J Infect Dis. 1983 Mar;147(3):576-84. doi: 10.1093/infdis/147.3.576.
2
In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.水痘带状疱疹病毒对E-5-(2-溴乙烯基)-2'-脱氧尿苷及相关化合物的体外敏感性
Antimicrob Agents Chemother. 1982 Jan;21(1):33-8. doi: 10.1128/AAC.21.1.33.
3
Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.(E)-5-(2-溴乙烯基)-2'-脱氧尿苷(BVDU)及其阿拉伯糖基衍生物(E)-5-(2-溴乙烯基)-1-β-D-阿拉伯呋喃糖基尿嘧啶(BVaraU)对表达水痘带状疱疹病毒或单纯疱疹病毒胸苷激酶的肿瘤细胞的体外和体内比较细胞毒性活性。
Cancer Gene Ther. 2000 Feb;7(2):215-23. doi: 10.1038/sj.cgt.7700108.
4
Inhibitory effects of selected antiviral compounds on newly isolated clinical varicella-zoster virus strains.所选抗病毒化合物对新分离临床水痘带状疱疹病毒株的抑制作用。
Tohoku J Exp Med. 1986 Mar;148(3):275-83. doi: 10.1620/tjem.148.275.
5
Influence of various experimental conditions on the inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on varicella-zoster virus replication in cell culture.各种实验条件对(E)-5-(2-溴乙烯基)-2'-脱氧尿苷在细胞培养中对水痘-带状疱疹病毒复制抑制作用的影响。
Tohoku J Exp Med. 1984 Aug;143(4):441-9. doi: 10.1620/tjem.143.441.
6
Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.抗水痘带状疱疹病毒核苷类似物的选择性比较。
Microbiol Immunol. 1995;39(3):201-6. doi: 10.1111/j.1348-0421.1995.tb02189.x.
7
Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.5-乙烯基嘧啶核苷类似物的合成及其抗病毒特性
Pharmacol Ther. 1984;26(1):1-44. doi: 10.1016/0163-7258(84)90049-4.
8
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?耐阿昔洛韦水痘带状疱疹病毒(VZV)突变株(OKA株)的体外筛选:阿昔洛韦与喷昔洛韦之间的差异?
Antiviral Res. 2004 Mar;61(3):181-7. doi: 10.1016/j.antiviral.2003.10.003.
9
Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.胸苷激酶缺陷(TK-)肿瘤细胞系对(E)-5-(2-溴乙烯基)-2'-脱氧尿苷(BVDU)及相关化合物的细胞生长抑制作用敏感性增加。
Anticancer Res. 1986 Sep-Oct;6(5):1077-84.
10
Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.(E)-5-(2-溴乙烯基)-2'-脱氧尿苷5'-三磷酸对水痘带状疱疹病毒(TK+和TK-株)DNA聚合酶的抑制作用比较
Mol Pharmacol. 1984 Sep;26(2):376-80.

引用本文的文献

1
Hydrogen Bonding (Base Pairing) in Antiviral Activity.氢键(碱基配对)在抗病毒活性中的作用。
Viruses. 2023 May 10;15(5):1145. doi: 10.3390/v15051145.
2
40 Years after the Registration of Acyclovir: Do We Need New Anti-Herpetic Drugs?阿昔洛韦注册 40 年后:我们是否需要新型抗疱疹药物?
Int J Mol Sci. 2022 Mar 22;23(7):3431. doi: 10.3390/ijms23073431.
3
Antiviral Drugs Against Herpesviruses.抗疱疹病毒药物。
Adv Exp Med Biol. 2021;1322:1-30. doi: 10.1007/978-981-16-0267-2_1.
4
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.β-l-1-[5-(E-2-溴乙烯基)-2-(羟甲基)-1,3-(二氧戊环-4-基)]尿嘧啶(l-BHDU)可在SCID-Hu小鼠模型中阻止水痘带状疱疹病毒复制,且不干扰5-氟尿嘧啶的分解代谢。
Antiviral Res. 2014 Oct;110:10-9. doi: 10.1016/j.antiviral.2014.07.007. Epub 2014 Jul 19.
5
Identification of a varicella-zoster virus replication inhibitor that blocks capsid assembly by interacting with the floor domain of the major capsid protein.鉴定出一种水痘-带状疱疹病毒复制抑制剂,该抑制剂通过与主要衣壳蛋白的底部结构域相互作用来阻断衣壳组装。
J Virol. 2012 Nov;86(22):12198-207. doi: 10.1128/JVI.01280-12. Epub 2012 Aug 29.
6
Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies.用于检测传染性水痘-带状疱疹病毒的报告细胞系的构建及其在抗病毒研究中的应用。
Antimicrob Agents Chemother. 2006 Sep;50(9):3142-5. doi: 10.1128/AAC.00342-06.
7
Brivudin (bromovinyl deoxyuridine).布立伏定(溴乙烯基脱氧尿苷)。
Drugs. 2004;64(18):2091-7; discussion 2098-9. doi: 10.2165/00003495-200464180-00011.
8
Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Collaborative Antiviral Study Group/AIDS Clinical Trials Group, Herpes Zoster Study Group.索立夫定与阿昔洛韦治疗人类免疫缺陷病毒感染患者的带状疱疹:一项随机对照临床试验的结果。协作抗病毒研究组/艾滋病临床试验组,带状疱疹研究组
Antimicrob Agents Chemother. 1998 May;42(5):1139-45. doi: 10.1128/AAC.42.5.1139.
9
In search of a selective antiviral chemotherapy.寻找一种选择性抗病毒化疗方法。
Clin Microbiol Rev. 1997 Oct;10(4):674-93. doi: 10.1128/CMR.10.4.674.
10
Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.所选抗病毒化合物对水痘-带状疱疹病毒临床分离株的比较活性。
Eur J Clin Microbiol Infect Dis. 1995 Apr;14(4):318-29. doi: 10.1007/BF02116525.